amgen glp-1 drug Amgen could threaten Novo Nordisk, Eli Lilly weight loss drug dominance

This JAMA Internal Medicine patient page covers #GLP1 weight loss medications, focusing on food craving reduction, blood glucose control, dietary strategies, exercise for muscle retention, and lifestyle changes to prevent weight regain. https: ja.ma Trends in the Development of GLP 1 Receptor Agonists Cardiovascular Actions and Clinical Outcomes With Glucagon Like Peptide 1 Receptor Agonists and Dipeptidyl Peptidase 4 Inhibitors Circulation Glucagon like peptide 1 receptor: mechanisms and advances in therapy Signal Transduction and Targeted Therapy Design, synthesis, and biological evaluation of a small molecule oral agonist of the glucagon like peptide 1 receptor ScienceDirect ADA 2025 Diabetes Guideline Highlights 1. Individualized First Line Therapy Metformin no longer mandatory as universal first line.Choice depends on patient phenotype + comorbidities: ASCVD, CKD, HF start with SGLT2 inhibitor